SENATE COMMITTEE ON HEALTH AND HUMAN SERVICES

 

 

May 2, 2001                                                                                                            Hearing Room B

1:00 PM                                                                                                                    Tapes 109 - 111

 

MEMBERS PRESENT:         Sen. Bill Fisher, Chair

Sen. Margaret Carter, Vice-Chair

Sen. Gary George

Sen. Frank Shields

Sen. Ken Messerle

 

STAFF PRESENT:                 Rick Berkobien, Administrator

Andrew Morris, Committee Assistant

 

MEASURES HEARD:                       SB 910 Work Session

                                                SB 567 Work Session

SB 9 Work Session

                                                SB 45 Public Hearing and Work Session

                                                SB 482 Public Hearing and Work Session

                                   

These minutes are in compliance with Senate and House Rules.  Only text enclosed in quotation marks reports a speaker’s exact words.  For complete contents, please refer to the tapes.

 

TAPE/#

Speaker

Comments

TAPE 109, A

004

Chair Fisher

Calls meeting to order at 1:20 p.m. and opens a work session on        SB 910.

SB 910 WORK SESSION

007

Rick Berkobien

Administrator.  Explains SB 910 to the committee.

013

Dr. Michael Skeels

State Public Health Laboratory.  Reviews health screening tests. 

020

Chair Fisher

Comments on the language of SB 910. 

050

Skeels

Reviews ORS 438.   

070

Chair Fisher

Provides personal opinion.  Asks if the language narrows the scope of testing.

080

Skeels

Responds no.

092

Sen. George

Asks what is wrong with the bill.

095

Skeels

Responds the problem is that the bill is not clear in intent. 

106

Chair Fisher

Reviews the intent of SB 910.

111

Skeels

Reiterates concerns. 

116

Sen. George

Asks about the discretion of labs.

121

Skeels

Responds labs have their own discretion.

126

Sen. Carter

Asks if the agency needs clear direction from the committee.

132

Skeels

Reviews current practices. 

156

Chair Fisher

Comments on various medical tests.  Clarifies his intents with SB 910.

189

Skeels

Reviews tests that can be done with blood samples.

205

Chair Fisher

Reiterates the intention of SB 910. 

224

Skeels

Reiterates the need for clear direction in SB 910. 

235

Chair Fisher

States the issue can be worked on during the interim. 

269

Chair Fisher

Closes the work session on SB 910 and opens a work session on        SB 567.

SB 567 WORK SESSION

288

Berkobien

Explains SB 567 to the committee.

384

Chair Fisher

Puts the committee at ease at 1:45 p.m.

385

Chair Fisher

Calls meeting back to order at 1:50 p.m.

TAPE 110, A

000

Chair Fisher

States the intention of SB 567 is to work with incontinent supplies..

023

Grover Simmons

Representing Adult Foster Homes.  Comments on a past rule making hearing at Senior and Disabled Services Division (SDSD). 

036

Chair Fisher

Comments on the affects of single source contracts in rural areas. 

041

Tom Holt

Oregon State Pharmacy Association.  Comments on the –2 amendments. 

054

Sen. Carter

MOTION:  Moves to ADOPT SB 567-2 amendments dated 04/17/01.

 

 

VOTE:  5-0

AYE:               5 - Carter, George, Messerle, Shields, Fisher

056

Chair Fisher

The motion CARRIES.

057

Sen. Carter

MOTION:  Moves SB 567 to the floor with a DO PASS AS AMENDED recommendation and BE REFERRED to the committee on Ways and Means.

 

 

VOTE:  5-0

AYE:               5 - Carter, George, Messerle, Shields, Fisher

065

Chair Fisher

The motion CARRIES.

066

Chair Fisher

Closes the work session on SB 567 and opens a work session on SB 9.

SB 9 WORK SESSION

068

Berkobien

Explains SB 9 to the committee.

090

Holt

Comments on SB 9.

107

Wayne Kragen

Dean, Oregon State University School of Pharmacy.  Testifies in support of SB 9. 

118

Sen. Carter

Comments on the –2 amendments. 

127

Connie Sealy

Legislative Director, Senate Democratic Office.  Reviews the –2 amendments. 

142

Chair Fisher

Comments on the costs of the –2 amendments.

146

Sealy

States that there is a proposed dispensing fee modeled after California’s law.  Explains (EXHIBIT A). 

185

Chair Fisher

Comments on the costs of the –2 amendments.

194

Sen. Carter

Reviews the intention of the –2 amendments.

200

Chair Fisher

States the responsibility of prescriptions is the federal government’s. 

217

Sen. Carter

Asks about the California law.

222

Sealy

Responds by explaining who supported the bill in California. 

233

Sen. Carter

Asks about fiscal savings.

244

Sealy

Comments on the revenue impact.  States the presented numbers are taken from the Legislative Revenue Office. 

256

Sen. Carter

Comments on the intention of the –2 amendments.

262

Chair Fisher

Provides personal opinion.

266

Holt

Reviews California law.  Comments on lost revenue from pharmacists.  States opposition to the –2 amendments.

315

Sealy

Reviews work that has been done.

339

Chair Fisher

Provides personal opinion. 

344

Sen. Carter

MOTION:  Moves to ADOPT SB 9-2 amendments dated 03/23/01.

348

Sen. Messerle

Asks about the decision to incorporate the –2 amendments.

358

Sealy

Responds she is unsure.

378

Kragen

States opposition to the –2 amendments.

 

 

VOTE:  2-3

AYE:               2 - Carter, Shields

NAY:               3 - George, Messerle, Fisher

398

Chair Fisher

The motion FAILS.

401

Sen. George

MOTION:  Moves to ADOPT SB 9-1 amendments dated 03/16/01.

 

 

VOTE:  3-2

AYE:               3 - George, Messerle, Fisher

NAY:               2 - Carter, Shields

405

Chair Fisher

The motion CARRIES.

407

Sen. George

MOTION:  Moves SB 9 to the floor with a DO PASS AS AMENDED recommendation and BE REFERRED to the committee on Ways and Means.

 

 

VOTE:  3-2

AYE:               3 - George, Messerle, Fisher

NAY:               2 - Carter, Shields

421

Chair Fisher

The motion CARRIES.

TAPE 109, B

000

Chair Fisher

Closes the work session on SB 9 and opens a public hearing on SB 45.

SB 45 PUBLIC HEARING

010

Berkobien

Explains SB 45 to the committee.

033

Jody Fischer

Oregon Academy of Ophthalmology.  Testifies in support of the –5 amendments (EXHIBIT B).  Comments on the agreement reached with the optometrists.  States the Optometrists later reversed the agreement.  Reviews the need for the –5 amendments.  Comments on the –7 amendments. 

092

Chair Fisher

Comments on the formulary council. 

100

Fischer

Comments on topical prescriptions. 

112

Chair Fisher

Provides personal opinion. 

126

Peggy Anet

Health Insurance Association of America.  Testifies on SB 45 (EXHIBIT C).  Comments on scope of practice issues.  Reviews changes made to the scope of practice by the Board of Optometry without statutory authority.  States that the Board of Optometry has written their rules in the form of questions.  Comments on oversight.

179

Sen. Carter

Asks for Anet’s opinion.

185

Anet

States support of the –5 amendments.

188

Jim Anderson

Oregon Medical Association (OMA).  States the OMA supports the –5 amendments.

200

Sen. Messerle

Asks for the differences of the –5 and the –7 amendments.

205

Fischer

Explains the difference.  Explains the impact and intention of the –7 amendments.

223

Sen. Messerle

Comments on services for patients. 

242

Fischer

Follows up to Sen. Messerle’s comments.  Comments on intention of the –5 amendments. 

260

Anet

States the –5 amendments are not a change from current practices. 

280

Sen. Messerle

States an interest in combining state boards.

295

Joan Miller

President, Oregon Board of Optometry.  Comments on the Board of Optometry.  Describes definitions of procedures.  Comments on the use of topical medications.  States disagreement of the –5 amendments. 

416

Sen. George

Asks why the –5 amendments do not work.

421

Miller

Responds the board’s attorney said the language did not work.

428

David Plunkett

Oregon Board of Optometry.  States the amendments do not protect Optometrists.

TAPE 110, B

000

Miller

Comments on the –7 amendments.

010

Sen. Carter

Asks how the –5 amendments could allow for the topical formulary to disappear.

018

Plunkett

Gives ways the formulary could be removed.  Reviews past laws.

048

Wayne Schumacher

Oregon Optometrist Physician Association.  Testifies in support of the –7 amendments.  Explains the difference between the –7 and –5 amendments.

079

Chair Fisher

Asks about the changes in administrative rules.

090

Miller

Responds how the changes were made in the administrative rules. 

129

Chair Fisher

Asks about the changes in the rules requiring Optometrists to consult with Ophthalmologists.

137

Miller

Responds the statute requires a medical doctor, not an Ophthalmologist.

149

Plunkett

Provides further comments.

154

Chair Fisher

Comments on the hearings to change the administrative rules.

165

Plunkett

Reviews how the hearings were set up. 

184

Miller

Comments on the hearing process. 

194

Chair Fisher

Asks about the development of administrative rules.

199

Miller

Gives her opinion of the administrative rule process. 

225

Chair Fisher

Asks if practitioners have to follow ORS even if the administrative rules do not incorporate them.

232

Miller

Responds affirmatively.

257

Fischer

Responds to previous testimony.  Comments on the opinion of legislative counsel.  States the intent of the –5 amendments is to grandfather in previous laws.

281

Anderson

States agreement with Fischer.  Comments on the administrative rule process. 

308

Sen. Carter

States her intention with the –5 amendments. 

328

Chair Fisher

Provides personal opinion. 

TAPE 111, A

000

Chair Fisher

Continues giving personal opinion.

058

Chair Fisher

Closes the public hearing on SB 45 and opens a work session on SB 45.

060

Sen. Carter

MOTION:  Moves to ADOPT SB 45-5 amendments dated 04/25/01.

 

 

VOTE:  2-3

AYE:               2 - Carter, Shields

NAY:               3 - George, Messerle, Fisher

076

Chair Fisher

The motion FAILS.

078

Sen. George

MOTION:  Moves to ADOPT SB 45-7 amendments dated 05/02/01.

 

 

VOTE:  4-1

AYE:               4 - George, Messerle, Shields, Fisher

NAY:               1 – Carter

093

Chair Fisher

The motion CARRIES.

095

Sen. Shields

MOTION:  Moves SB 45 to the floor with a DO PASS AS AMENDED recommendation.

 

 

VOTE:  4-1

AYE:               4 - George, Messerle, Shields, Fisher

NAY:               1 – Carter

106

Chair Fisher

The motion CARRIES.

SEN. FISHER will lead discussion on the floor.

108

Chair Fisher

Closes the work session on SB 45 and opens a public hearing on            SB 482.

SB 482 PUBLIC HEARING

111

Berkobien

Explains SB 482 to the committee.

133

Dr. Katrina Hedberg

Oregon Health Division.  Testifies in support of the –1 amendments.

141

Chair Fisher

Closes the public hearing on SB 482 and opens a work session on       SB 482.

SB 482 WORK SESSION

143

Sen. Carter

MOTION:  Moves to ADOPT SB 482-1 amendments dated 04/11/01.

 

 

VOTE:  5-0

AYE:               5 - Carter, George, Messerle, Shields, Fisher

158

Chair Fisher

The motion CARRIES.

162

Sen. Carter

MOTION:  Moves SB 482 to the floor with a DO PASS AS AMENDED recommendation.

 

 

VOTE:  5-0

AYE:               5 - Carter, George, Messerle, Shields, Fisher

177

Chair Fisher

The motion CARRIES.

SEN. CARTER will lead discussion on the floor.

188

Chair Fisher

Closes the work session on SB 482 and adjourns the meeting at       3:30 p.m.

 

Submitted By,                                                                           Reviewed By,

 

 

 

Andrew Morris,                                                                        Rick Berkobien,

Committee Assistant                                                                 Administrator

 

EXHIBIT SUMMARY

 

A – SB 9, Figure sheet, Connie Sealy, 1 p.

B – SB 45, Written testimony, Jody Fischer, 10 pp.

C – SB 45, Statutes and information, Peggy Anet, 11 pp.